Indus Capital Partners, LLC Vir Biotechnology, Inc. Transaction History

Indus Capital Partners, LLC

  • $148 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$27.89 - $47.86 $2.44 Million - $4.19 Million
-87,638 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$12.04 - $60.2 $7.16 Million - $35.8 Million
-594,298 Reduced 87.15%
87,638 $3 Million
Q4 2019

Feb 14, 2020
BUY
$11.83 - $15.85 $8.07 Million - $10.8 Million
681,936 New
681,936 $8.58 Million

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $974M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Indus Capital Partners, LLC Portfolio

Follow Indus Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Indus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Indus Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email